Gabriel Leung, Director at NovoCure Ltd (NVCR), sold 19,565 shares at $95.00 ($1.9M) on 2020-09-14, disclosed to the SEC on 2020-09-16.
Open-market sale of $1.9M NVCR by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $95.00 | 10,000 | $950K | 49.8% |
| 2 | $100.00 | 2,173 | $217K | 11.4% |
| 3 | $100.00 | 7,392 | $739K | 38.8% |
| Total | $97.44 avg | 19,565 | $1.9M | 100% |
| Filing → |
| NVCR | SELL | 2024-06-06 | $23K | — | Filing → |
| NVCR | SELL | 2021-08-06 | $153K | — | Filing → |
| NVCR | SELL | 2021-07-08 | $184K | — | Filing → |